1. EXERCISE 11: Computing and Analyzing Program Indicators
You will be given the following 2012 annual reports for Province X in Region 5. (note: consolidation of quarterly reports)
Report 1. Quarterly Report on TB Microscopy and GX Laboratory Examinations
Report 2. Quarterly Report on EQA for TB Microscopy
Report 3a. Quarterly Report on Case Finding of Drug- susceptible TB Cases and IPT
Report 5a. Quarterly Report on Treatment Outcome of Drug- susceptible TB Cases

2. From the reports above, compute for the following indicators:
Case Notification Rate (all forms)
TB Case Detection Rate (all forms) – use 260/100k as incidence rate for exercise
Treatment Success Rate (all forms)
Cure Rate (new bacteriologically confirmed)
Total number of presumptive TB examined
Percent contribution from non-NTP care providers
Number of children with TB detected and given treatment and those given IPT
Percentage of TB cases in category A and B areas with HIV counseling and testing among aged 15 years old and above
Percent of TMLs within EQA standards

3. CORRECTIONS on the DATA given:
Report 5a. Quarterly Report on Treatment Outcome of Drug-susceptible TB Cases
A. Bacteriologically Confirmed New and Relapse TB Cases
Total number of TB cases
Cured
Comple ted
Died
Failed
Lost to follow-up
Not Evalua ted
TOTAL
1,126
New
846
176 8 12 72 9
1,123 38
Relapse 25 3 1 5 34
B . Clinically Diagnosed New and Relapse TB Cases
Total number of TB cases
Comple ted
Died
Failed
Lost to follow-up
Not Evalua ted
TOTAL
1,624
New
1,522 3 84 14
1,623 35
Relapse 30 33
D. Source of All New and Relapse Cases
Total number of notified TB Cases, all forms
Public Walk-in patients
Other Public Facilities
Private Sector
Community
2,688
2,123 81
323
161

4. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
1.  Case Notification Rate (all forms)
No. TB, all forms
population divided by 100,000
From Report 3a., table A and B, get the total number of all forms (new and relapse)
“all forms” include new, relapse, and extrapulmonary TB cases (whether bacteriologically confirmed or clinically diagnosed)

5. Report 3a. Quarterly Report on Case Finding of Drug- Susceptible TB Cases and IPT
Point out where to get the “all forms” (numerator) to compute the indicator

6. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
1.  Case Notification Rate (all forms)
No. TB, all forms
=2,688
population divided by 100,000
1,234,345
100,000
218

7. Previously Treated (except Relapse) TOTAL
Report 3a. Quarterly Report on Case Finding of Drug-susceptible TB Cases and IPT
(Data Source: Form 6a. Drug-susceptible TB Register and Form 9. IPT Register)
A. Bacteriologically confirmed TB Cases registered during the quarter by registration group and sex
CLASSIFICATION
NEW
RELAPSE
Previously Treated (except Relapse)
TOTAL M F
Pulmonary
678
392 10 7 19 16
707
415
Extrapulmonary 14 2 1 5 4 20 8
Subtotal
692
394 11 9 24
727
423
1,086 44
1,150
B. Clinically diagnosed TB Cases registered during the quarter by registration group and sex
CLASSIFICATION
NEW
RELAPSE
Previously Treated (except Relapse)
TOTAL M F
Pulmonary
789
716 16 17 52 36
857
769
Extrapulmonary 28 15 1 7 6 21
Subtotal
817
731 59 42
893
790
1,548 34
101
1,683

8. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
1.  Case Notification Rate (all forms)
1,086
+ 20
+1,548
+34
= 2,688
1,234,345
100,000
= 12.34
2,688
12.34
= 218

9. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
2.  TB Case Detection Rate (all forms)
Number of all forms of TB detected
Total number of all forms estimated to occur each year (i.e., population x incidence rate of TB, all forms) 
From Report 3a., table A and B, get the total number of all forms (new and relapse)
used incidence rate of 260/100k for this exercise

10. Report 3a. Quarterly Report on Case Finding of Drug- Susceptible TB Cases and IPT
Point out where to get the “all forms” (numerator) to compute the indicator

11. general notes in analysis
numerator
denominator
Computed
remarks
general notes in analysis
2.  TB Case Detection Rate (all forms)
Number of all forms of TB detected
=2,688
Total number of all forms estimated to occur each year (i.e., population x incidence rate of TB, all forms) 
=3,209
84%

12. Previously Treated (except Relapse) TOTAL
Report 3a. Quarterly Report on Case Finding of Drug-susceptible TB Cases and IPT
(Data source: Form 6a. Drug-susceptible TB Register and Form 9. IPT Register)
A. Bacteriologically confirmed TB Cases registered during the quarter by registration group and sex
CLASSIFICATION
NEW
RELAPSE
Previously Treated (except Relapse)
TOTAL M F
Pulmonary
678
392 10 7 19 16
707
415
Extrapulmonary 14 2 1 5 4 20 8
Subtotal
692
394 11 9 24
727
423
1,086 44
1,150
B. Clinically diagnosed TB Cases registered during the quarter by registration group and sex
CLASSIFICATION
NEW
RELAPSE
Previously Treated (except Relapse)
TOTAL M F
Pulmonary
789
716 16 17 52 36
857
769
Extrapulmonary 28 15 1 7 6 21
Subtotal
817
731 59 42
893
790
1,548 34
101
1,683

13. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
2.  TB Case Detection Rate (all forms)
1,086
+ 20
+ 1,548
+ 34
= 2,688
1,234,345
X .0026
= 3,209
2,688
3,209
= 84%
Used incidence rate of 260/100k 

14. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
3. Treatment Success Rate (all forms)
Number of All forms of TB cases cured and completed treatment
Total number of all forms of TB cases registered during a specified period
From Report 5a, add all cured and completed for new and relapse cases in Section A and B. Denominator will be total new and relapse evaluated.

15. Report 5a. Quarterly Report on Treatment Outcome of Drug-susceptible TB Cases
Numerator will be the blue circle—”all forms” (new and Relapse) that were cured and treatment completed for both BC and CD.
Denominator will be red circle or TOTAL.
Note: If the total does not match with cases registered the previous year (1st column), this may be due to the number on the footnote or “excluded from cohort because found to be DRTB regimen”.
“Missing cases” (that is=total number of new and relapse registered last year minus total evaluated minus excluded) should be added to the denominator as “not evaluated” so that the discrepancy will be accounted for.

16. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
3. Treatment Success Rate (all forms)
Number of all forms of TB cases cured and completed treatment
=2,602
Total number of all forms of TB cases registered during a specified period
=2,813
92%

17. A. Bacteriologically Confirmed New and Relapse TB Cases
Report 5a. Quarterly Report on Treatment Outcome of Drug-susceptible TB Cases
A. Bacteriologically Confirmed New and Relapse TB Cases
Total number of TB cases
Cured
Comple ted
Died
Failed
Lost to follow
Not Evalua ted
TOTAL
1,126
New
846
176 8 12 72 9
1,123 38
Relapse 25 3 1 5 34
Note: Exclude from the cohort the cases found to be drug resistant at anytime during treatment.
Number of cases excluded from the cohort= __7_______
B . Clinically Diagnosed New and Relapse TB Cases
Total number of TB cases
Comple ted
Died
Failed
Lost to follow
Not Evalua ted
TOTAL
1,624
New
1,522 3 84 14
1,623 35
Relapse 30 33
Note: Exclude from the cohort cases found to be drug resistant at anytime during treatment.
Number of cases excluded from the cohort= ___3________

18. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
3. Treatment Success Rate (all forms)
+1522
+30
= 2,602
+ 1623
+ 33
=2,813
2,602
2,813
X 100
= 92%

19. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
4. Cure Rate (New Bacteriologically-confirmed)
No. of new bacteriologically-confirmed TB cases cured
Total number of new bacteriologically-confirmed TB cases registered during a specified period
From Report 5a, get cured for new bacteriologically confirmed cases, Section A. Denominator will be total new and relapse evaluated.

20. Report 5a. Quarterly Report on Treatment Outcome of Drug-susceptible TB Cases

21. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
4. Cure Rate (new bacteriologicallyconfirmed)
No. of new bacterio-logically-confirmed TB cases cured
=846
Total number of new bacterio-logically-confirmed TB cases registered during a specified period
=1,123
=75%

22. Total number of TB cases
Report 5a. Quarterly Report on Treatment Outcome of Drug-susceptible TB Cases
A. Bacteriologically Confirmed New and Relapse TB Cases
Total number of TB cases
Cured
Comple ted
Died
Failed
Lost to follow
Not Evalua ted
TOTAL
1,126
New
846
176 8 12 72 9
1,123 38
Relapse 25 3 1 5 34
Note: Exclude from the cohort cases found to be drug resistant at anytime during treatment.
Number of cases excluded from the cohort = __7_

23. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
4. Cure Rate (new bacteriologically confirmed)
=846
=1,123
846
1,123
X 100
=75%

24. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
5. Total number of presumptive TB examined
number of presumptive TB examined during the reporting period
From Report 1a, get the total number examined by DSSM (#1).

25. Report 1. Quarterly Report on TB Microscopy and GX Laboratory Examinations
Presumptive examined will refer to those that underwent DSSM.
It does not include presumptive TB children who did not undergo DSSM and does not include Xpert.
Note: reason for this is that under PhilPACT, this indicator was intended as a measure of access to microscopy services.

26. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
5. Total number of presumptive TB examined
number of presumptive TB examined during the reporting period
=8,234
=8234

27. Laboratory Activities Other Retreatment Cases
Report 1a.Quarterly Report on TB Microscopy and GX Laboratory Examinations
Case Finding:
Laboratory Activities
DSSM
Xpert
New
Relapse
Other Retreatment Cases
No. Examined
8,234 25 70
2. No. with positive examination result:
1,234 4 12
3. Positivity Rate*
15%
4. No. of presumptive TB case with rifampicin resistance 3 8

28. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
5. Total number of presumptive TB examined
8,234

29. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
6.  Percent contribution from non-NTP care providers
No. of notified TB cases, all forms, referred/ managed by all non-NTP care providers (other government, private, community, etc.)
Total number of notified TB cases, all forms
From Report 3a., table D, add the total number from other public facilities, private and community. Denominator will be total notified TB cases, all forms.

30. Report 3a. Quarterly Report on Case Finding of Drug- susceptible TB Cases and IPT
Non-NTP Providers

31. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
6.  Percent contribution from non-NTP care providers
No. of notified TB cases, all forms, referred/
managed by all non-NTP care providers (other government, private, community, etc.)
=565
Total number of notified TB cases, all forms
=2,688
= 21%

32. Report 3a. Quarterly Report on Case Finding of Drug-susceptible TB Cases and IPT
C. All New and Relapse TB Cases by Age and Sex
0 to 4
5 to 14
15 to 24
25 to 34
35 to 44
45 to 54
55 to 64
>=65
TOTAL M F
New 32 20
319
281
250
164
313
200
289
150
104 90
106 89 77
1,532
1,102
Relapse 7 5 16 11 2 4 1 34
Subtotal
257
169
329
211
294
152
154
105 92
107
1,566
1,122 52
600
426
540
446
259
199
166
2688
D. Source of All New and Relapse Cases
Total number of notified TB Cases, all forms
Public Walk-in patients
Other Public Facilities
Private Sector
Community
2,688
2,123 81
323
161

33. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
6.  Percent contribution from non-NTP care providers 81
+ 323
+ 161
= 565
= 2,688
565
2,688
X 100
= 21%

34. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
7.  Number of children with TB detected and given treatment and those given IPT
Absolute number of children with TB detected and given treatment plus those given IPT
From Report 3a, add children treated in Table E and given IPT in Table G

35. TB in children (add to IPT below)
Report 3a. Quarterly Report on Case Finding of Drug- susceptible TB Cases and IPT
TB in children (add to IPT below)
IPT among children

36. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
7.  Number of children with TB detected and given treatment and those given IPT
Absolute number of children with TB detected and given treatment plus those given IPT
= 772
=772

37. Total TB cases less than 15 years old
Report 3a. Quarterly Report on Case Finding of Drug-susceptible TB Cases and IPT
E. TB in Children
Total TB cases less than 15 years old
Number
Pulmonary
631
Extrapulmonary 21
F. HIV Status among aged 15 years and above
G. Individuals Given IPT
Number given IPT
Children age 0-4 (without HIV)
120
PLHIV

38. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
7.  Number of children with TB detected and given treatment and those given IPT
631
+ 21
+ 120
= 772
=772

39. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
8.  Percentage of TB cases in Category A and B areas with HIV counseling and testing among aged 15 years old and above
Number of registered TB cases in Category A and B areas provided with HIV counseling and testing among 15 years old and above
Total number of registered TB cases in Category A and B areas 15 years old and above
From Report 3a, Table F, get the number tested or known HIV status and divide by total number registered for quarter that are 15 y/o above.

40. Tested for HIV among those eligible
Report 3a. Quarterly Report on Case Finding of Drug- Susceptible TB Cases and IPT
Tested for HIV among those eligible

41. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
8.  Percentage of TB cases in Category A and B areas with HIV counseling and testing among aged 15 years old and above
Number of registered TB cases in Category A and B areas provided with HIV counseling and testing among 15 years old and above
=1,906
Total number of registered TB cases in Category A and B areas 15 years old and above
=2,171
= 88%

42. Report 3a. Quarterly Report on Case Finding of Drug-susceptible TB Cases and IPT
F. HIV Status among aged 15 years and above
Classification of Cases
Number of Cases registered for the quarter
No. of cases tested or with known HIV status during the quarter
No. of TB cases confirmed positive for HIV
Among HIV positive, number given
ART
CPT
Pulmonary
2,159
1,894
Extrapulmonary 12

43. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
8.  Percentage of TB cases in Category A and B areas with HIV counseling and testing among aged 15 years old and above
1,894
+ 12
=1,906
2,159
=2,171
1,906
2,171
X 100
=88%

44. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
9. Percent of TMLs within EQA standards
Number of TMLs who have less than 5% major errors (adequate performance)
All TMLs providing TB laboratory services within the NTP laboratory network
From Report 2a, get the total number of TMLs within EQA standard and divide by total number of TMLs.

45. Report 2. Quarterly Report on EQA for TB Microscopy
Adequate performance = those with less than 5% ME over TOTAL TMLs

46. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
9. Percent of TMLs within EQA standards
Number of TMLs who have less than 5% major errors (adequate performance)
=11
All TMLs providing TB laboratory services within the NTP laboratory network
=15
=73%

47. TB Microscopy Laboratory EQA: On-site Evaluation
Report 2. Quarterly Report on External Quality Assessment for TB Microscopy
(Data Source: Quality Assurance Center Records)
TB Microscopy Laboratory
Public
Private
TOTAL
No. of TB microscopy laboratories (TML) (A) 10 5 15
TML participating in EQA (B)
(B/A) x 100 1 11
100%
20%
73%
TML with <5% major errors (C)
(C/A) x 100
EQA: On-site Evaluation
Number
TMLs with major error/s (D) 3
Feedback done by the QAC Team to discuss corrective actions (E) 2
Percentage, E/D (%)
67%

48. general notes in analysis
numerator
denominator
computed
remarks
general notes in analysis
9. Percent of TMLs within EQA standards
=11
=15 11 15
X 100
=73%